$CRVS https://www.phillyvoice.com/temple-covid19-immunotherapy-clinical-trial-corvus-coronavirus-research/ https://clinicaltrials.gov/ct2/show/NCT04464395?type=Intr&cond=COVID-19&sort=nwst&draw=2 Corvus Pharmaceuticals is managed by PCYC management ($21 billion buyout), worth a look!